Meeting
2024 ASCO Annual Meeting
Accuracy of medical oncology prognosis for patients with metastatic cancer evaluated for enrollment onto an ongoing randomized clinical trial.
Authors
Shearwood McClelland III
University Hospitals Seidman Cancer Center, Department of Radiation Oncology, Case Western Reserve University School of Medicine, Cleveland, OH
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Symptom Science and Palliative Care
Track
Symptom Science and Palliative Care
Sub Track
Palliative Care and Symptom Management
Citation
J Clin Oncol 42, 2024 (suppl 16; abstr 12063)
DOI
10.1200/JCO.2024.42.16_suppl.12063
Abstract #
12063
Poster Bd #
192
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Phase II study of hemithoracic intensity-modulated pleural radiation therapy (IMPRINT) for patients with pleural metastases from thymic malignancies.
First Author: Andreas Rimner
Poster
2023 ASCO Annual Meeting
A phase II randomized trial of talimogene laherparepvec (T-VEC) oncolytic immunotherapy with or without radiotherapy for patients with cutaneous metastases from solid tumors.
First Author: Christopher A. Barker
Poster
2023 ASCO Annual Meeting
A phase II study of nivolumab and ipilimumab with radiation therapy in patients with metastatic, microsatellite stable colorectal cancer.
First Author: Julie L. Koenig
Poster
2023 ASCO Annual Meeting
A phase II study of nivolumab and ipilimumab with radiation therapy in patients with metastatic, microsatellite stable pancreatic adenocarcinoma.
First Author: Julie L. Koenig